Updates matching "Tobacco Regulation and Products"

A new survey released today from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) finds youth tobacco use remains a serious public health threat.

Tonight the House is considering a long-overdue FY2022 funding bill that addresses critical aspects of cancer research, prevention and access to care.

Wednesday marks six months since the U.S. Food and Drug Administration (FDA) failed to meet its court-ordered deadline to rule on all e-cigarette and other new tobacco product manufacturers’ applications.

head of the president’s State of the Union Address, the American Cancer Society Cancer Action Network (ACS CAN) is offering numerous policy suggestions for ways in which the administration and Congress can achieve the president’s ambitious Cancer Moonshot goal.

Statement from ACS CAN on the confirmation of FDA Commissioner Dr. Robert Califf

The Food and Drug Administration (FDA) today authorized the marketing of two low-nicotine cigarettes as “modified risk tobacco products,” including one product that is menthol-flavored.

ACS CAN looks forward to working with the new New York City Mayor and City Council Speaker on crucial health issues.

The U.S. Food and Drug Administration (FDA) opposed public health groups’ request that the agency provide regular status reports to a U.S. District Judge and estimate the dates it expects to complete its review of applications for products that rank among the top 10 brands in market share.

The Food and Drug Administration announced this afternoon it has issued marketing orders for the first e-cigarette products authorized by the agency.